Fennec Pharmaceuticals Inc (NASDAQ: FENC) stock enjoyed a major increase of 11.4% on 3/18/24. The shares closed at $11.07. However, exceptionally low trading volume at 0% of normal accompanied the advance. The stock has been exceptionally strong relative to the market over the last nine months and has risen 14.6% during the last week.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, FENC is expected to be a major Value Eraser.
Fennec Pharmaceuticals is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment